Prot #KCP-330-020: A Phase 2-3, Multicenter, Randomized, Double-Blind Study of Selinexor (KPT-330) Versus Placebo in Patients with Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/27/182/27/21

Funding

  • Clintrax Global, Inc. (Prot #KCP-330-020)
  • Karyopharm Therapeutics Inc. (Prot #KCP-330-020)